These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2676032)

  • 1. Hematologic aspects of renal insufficiency.
    Schiller GJ; Berkman SA
    Blood Rev; 1989 Sep; 3(3):141-6. PubMed ID: 2676032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic aspects of end-stage renal failure.
    Zachée P; Vermylen J; Boogaerts MA
    Ann Hematol; 1994 Jul; 69(1):33-40. PubMed ID: 8061105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anemia in chronic renal insufficiency].
    Feiman R; Mena Castro E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(2):231-41. PubMed ID: 7259844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematologic complications of chronic renal failure.
    Fried W
    Med Clin North Am; 1978 Nov; 62(6):1363-79. PubMed ID: 368451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal anemia and thrombopathy].
    Blumberg A
    Verh Dtsch Ges Inn Med; 1974; 80():625-8. PubMed ID: 4616502
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D; Djukanović Lj; Lezajić V
    Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic disorders in renal failure.
    Naets JP
    Nephron; 1975; 14(2):181-94. PubMed ID: 1093056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of recombinant human erythropoietin therapy on renal transplantation.
    Ettenger RB; Marik J; Grimm P
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):57-61. PubMed ID: 1928081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
    Bommer J; Huber W; Tewes G; Ritz E; von Wedel S; Küppers S; Weinreich T; Bommer G
    Contrib Nephrol; 1988; 66():131-8. PubMed ID: 3391027
    [No Abstract]   [Full Text] [Related]  

  • 15. Anemia treatment with erythropoietin in pregnant renal recipients.
    Cyganek A; Pietrzak B; Kociszewska-Najman B; Sanko-Resmer J; Paczek L; Wielgos M
    Transplant Proc; 2011 Oct; 43(8):2970-2. PubMed ID: 21996203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin.
    Jones-Lecointe A; Green PJ; Lee HA
    Clin Lab Haematol; 1991; 13(3):251-3. PubMed ID: 1794227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.
    Eschbach JW
    Kidney Int; 1989 Jan; 35(1):134-48. PubMed ID: 2651751
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of renal anemia.
    Eckardt KU
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S2-8. PubMed ID: 10746799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
    Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
    Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.